期刊文献+

百贝宁治疗轮状病毒肠炎疗效观察 被引量:2

Clinical Observation of Therapeutic Effects of Baibeining on Rotavirus Enteritis
下载PDF
导出
摘要 目的探讨百贝宁对轮状病毒肠炎治疗效果.方法观察轮状病毒肠炎76例,随机分为治疗组40例,对照组36例.两组基础治疗均采用利巴韦林10 mg/(kg.d)静脉点滴,蒙托石散、双歧杆菌口服,补液支持治疗.治疗组在上述基础上给与百贝宁1g/次口服,3次/d,共3~5 d.对照组采用干扰素α-1b肌注10ug/(kg.次)肌肉注射,1次/d,3~5 d.结果治疗组显效率70%,总有效率92.5%,对照组显效率38.9%,总有效率72.2%,两组比较差异有统计学意义(P<0.05),治疗组脱水纠正时间及住院天数较对照组短,比较差异有统计学意义(P<0.01),治疗组及对照组出现迁延性腹泻百分比,两组比较差异有统计学意义(P<0.05).结论百贝宁能有效改善轮状病毒肠炎的症状、体征,有效减少迁延性腹泻的发生,有效率优于对照组,临床疗效优于干扰素,并具有口感好,无不良反应等特点. Objective To investigate the therapeutic effects of Baibeining on rotavirus enteritis.Methods 76 cases of rotavirus enteritis were observed,which were randomly divided into treatment group(40 cases)and control group(36 cases).Patients in both treatment group and control group were basically treated with ribavirin(10 mg/(kg.d),iv),smectite powder and bifidobacterium(p.o.),and fluid infusion supportive treatment.Based on the basic intervention,Baibeining(100 g,tid,3~5 d)was applied in the treatment group,while interferon α1-b(1 mg/kg,qd,3~5 d)was applied in the control group.Results Obvious effective rate of treatment group was 70.0%,and total effective rate was 92.5%.Obvious effective rate of control group was 38.9%,and total effective rate was 72.2%.The difference between treatment group and control group was statistically significant(P〈0.05).The time for dehydration correction and hospitalization in treatment group were shorter than control group.The difference between treatment group and control group was statistically significant(P〈0.01).Conclusions Baibeining can effectively improve symptoms and physical signs in patients with rotavirus enteritis,and reduce the incidence of persisting diarrhea.The therapeutic effects of Baibeining are better than that of interferon.Furthermore,Baibeining has good taste and less adverse reactions
作者 肖红梅
出处 《昆明医学院学报》 2011年第4期74-76,共3页 Journal of Kunming Medical College
关键词 百贝宁 轮状病毒肠炎 干扰素Α-1B Baibeining Rotavirus enteritis Interferonα-1b
  • 相关文献

参考文献4

二级参考文献8

共引文献27

同被引文献40

  • 1胡亚美 江载芳.实用儿科学第7版[M].北京:人民卫生出版社,2002,12.775.
  • 2Santos N , Hoshino Y . Global distribution of rotavirus serotypes/ genotypes and its implication for the development and implementa- tion of an effective rotavirus vaccine [ J]. Rev Med Virol, 2005, 15 ( 1 ) : 29-56.
  • 3Tare JE, Burton AH, Bosch PC, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years be- fore the introduction of universal rotavims vaccination programmes : a systematic review and meta-analysis [ J ]. Lancet Infect Dis, 2012, 12(2): 136-141.
  • 4Kang G, Desai R, Arora R, et al. Diversity of circulating rotavir- us strains in children hospitalized with diarrhea in India, 2005- 2009[J]. Vaccine, 2013, 31(27): 2879-2883.
  • 5Elizabeth P, Mathew D, Esona D, et al. Molecular Surveillance of Rotavirus Infection in the Democratic Republic of the Congo Au- gust 2009-June 2012 [J]. Pediatr Infect Dis J, 2014, 33 (4) : 355 -359.
  • 6Farkas T, Zhong WM, Jing Y, et al. Genetic diversity among sapoviruses[J]. Arch Virol, 2004, 149(7) : 1309-1323.
  • 7Jeong HS, Jeong A, Cheon DS. Epidemiology of astrovirus infec- tion in children[J]. Korean J Pediatr, 2012, 55(3) : 77-82.
  • 8Walsh MP, Seto J, Liu EB, et al. Computational analysis of two species C human adenoviruses provides evidence of a novel virus [J]. Clin Microbiol, 2011, 49(10) : 3842-3490.
  • 9Kitajima M, Haramoto E, Phanuwan C, et al. Prevalence and genetic diversity of Aichi viruses in wastewater and river water in Japan [ J ]. Appl Environ Microbiol, 2011, 77 ( 6 ) : 2184-2187.
  • 10Harvala H, Simmond P. Human parechoviruses: Biology, epide- miology and clinical significance [J].Clin Viral, 2009, 45 ( 1 ) : 1-9.

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部